CD33 and neoplasm: Previous studies have shown that NK-cell-mediated cytotoxicity could occur by CD16 × CD33 (1633) BiKEs that ligated CD16 on NK cells and CD33 on tumor cells, including myelodysplastic syndromes (MDS) and AML [86,87].